Cannabis and Vascular Disease: The Hidden Cardiovascular Risks

Citable definition: Cannabis-associated vascular disease refers to a spectrum of cardiovascular and peripheral vascular injuries — including acute coronary syndromes, stroke, and cannabis-related arteritis — triggered or accelerated by exposure to cannabinoids, primarily tetrahydrocannabinol (THC), through mechanisms involving endocannabinoid receptor activation, sympathetic nervous system stimulation, and prothrombotic (clot-promoting) effects on the vascular endothelium (inner lining of blood vessels).

What Is Cannabis-Associated Vascular Disease?

Cannabis is now the most widely used illicit substance globally, according to the UNODC World Drug Report, and in many jurisdictions it is no longer illicit at all. As legalization spreads across North America, parts of Europe, and beyond, a growing body of evidence is raising an uncomfortable question: what is cannabis doing to our blood vessels?

The cardiovascular effects of cannabis are not new to researchers, but they remain poorly understood by the general public — and, frankly, by a significant portion of prescribers. The active compound in cannabis, delta-9-tetrahydrocannabinol (THC), binds to cannabinoid receptors (CB1 and CB2) found throughout the cardiovascular system. This binding triggers a cascade of effects: an initial surge in heart rate and blood pressure, followed by vasodilation (widening of blood vessels) and, in some contexts, paradoxical vasoconstriction (narrowing of blood vessels). The net result is a cardiovascular system under stress — and for those with pre-existing vascular risk factors, that stress can tip into frank disease.

A 2014 review by Volkow and colleagues, published in the New England Journal of Medicine, provided a comprehensive overview of the adverse health effects of marijuana, noting that acute cannabis use is associated with a significant increase in heart rate. [Note: independent verification of the specific claims attributed to this source was not possible as the abstract was not available for review; the citation is provided for reference.] The risk of myocardial infarction (heart attack) is elevated in the hour immediately following cannabis use — a finding suggested by several studies, including Mittleman et al. (2001) and subsequent epidemiological work.

The Vascular Spectrum: From Heart Attack to Arteritis

Cardiac Events

The most acutely dangerous cardiovascular complication of cannabis use is acute coronary syndrome (ACS) — the umbrella term for heart attacks and unstable angina (severe chest pain caused by reduced blood flow to the heart). A 2017 paper by Goyal, Awad, and Ghali in the Journal of Thoracic Disease discussed mechanisms by which cannabis may promote these events (Goyal H et al., J Thorac Dis, 2017). [Note: independent verification of the specific mechanisms attributed to this source — including carboxyhemoglobin formation and platelet aggregation — was not possible as the abstract was not available for review; these mechanistic claims should be interpreted with appropriate uncertainty.] Proposed mechanisms in the broader literature include increased myocardial oxygen demand (the heart needing more oxygen than it receives), coronary artery spasm, carboxyhemoglobin formation from smoke inhalation, and platelet aggregation (clumping of platelets that can block arteries). Critically, these events are disproportionately reported in young, otherwise healthy individuals — a demographic not typically considered at high cardiac risk.

Stroke and Cerebrovascular Events

Cannabis use has been associated with both ischemic stroke (caused by a blockage) and hemorrhagic stroke (caused by bleeding). The proposed mechanisms include cerebral vasospasm, cardiac embolism (clots traveling from the heart to the brain), and cannabis-induced arrhythmias (abnormal heart rhythms) such as atrial fibrillation. Young cannabis users presenting with stroke represent a clinically distinct and increasingly recognized population.

Cannabis Arteritis: The Peripheral Vascular Threat

Perhaps the most insidious vascular complication — and the one most relevant to our readership interested in peripheral vascular disease — is cannabis arteritis. This is a form of peripheral artery disease (PAD — narrowing of the arteries supplying the limbs) that bears a striking resemblance to Buerger’s disease (thromboangiitis obliterans, a severe inflammatory disease of small and medium vessels strongly associated with tobacco use).

The French pharmacovigilance network, the CEIP-A (Centres d’Évaluation et d’Information sur la Pharmacodépendance-Addictovigilance) Working Group on Cannabis, published a 2014 report in Fundamental & Clinical Pharmacology on serious cardiovascular disorders in cannabis users (CEIP-A Working Group on Cannabis, Fundam Clin Pharmacol, 2014). [Note: independent verification of the specific findings attributed to this source — including peripheral arteritis, limb ischemia, amputations, patient demographics, and cannabis as the primary substance — was not possible as the abstract was not available for review; these details should be confirmed against the original publication.] According to available data, cannabis arteritis cases have been notable for the youth of the patients, the severity of the ischemia, and the prominent role of cannabis use.

Cannabis arteritis typically affects the distal vessels (the smaller arteries of the hands and feet), causing pain, color changes, ulceration, and in severe cases, gangrene requiring amputation. Unlike atherosclerotic PAD — which tends to affect older patients with classical risk factors — cannabis arteritis can strike patients in their twenties and thirties.

Symptoms: What to Watch For

Vascular symptoms related to cannabis use can be acute (appearing suddenly) or chronic (developing gradually). Organized by clinical frequency:

Most common:

• Palpitations (awareness of a rapid or irregular heartbeat) during or after cannabis use
• Chest tightness or pain, particularly in the first hour after smoking
• Dizziness or near-fainting (presyncope), related to blood pressure fluctuations

Peripheral vascular warning signs:

• Claudication — cramping pain in the calves, thighs, or buttocks that appears during walking and resolves with rest; a hallmark of PAD
• Cold, pale, or bluish fingers and toes (Raynaud-like phenomenon)
• Non-healing sores or ulcers on the feet or lower legs
• Asymmetric limb temperature (one foot noticeably colder than the other)

Neurological red flags:

• Sudden weakness or numbness on one side of the body
• Slurred speech or facial drooping
• Sudden severe headache — these symptoms constitute a medical emergency; call emergency services immediately

Diagnosis: What Your Doctor Will Look For

If a vascular specialist suspects cannabis-associated vascular disease, the diagnostic workup will typically include:

• Ankle-brachial index (ABI): A simple, non-invasive test comparing blood pressure at the ankle and the arm to detect PAD
• Duplex ultrasound: Imaging that combines traditional ultrasound with Doppler technology to visualize blood flow through vessels
• CT angiography or MR angiography: Cross-sectional imaging to map the arterial tree and identify areas of stenosis (narrowing) or occlusion (blockage)
• Echocardiography: Ultrasound of the heart to detect structural abnormalities or clot sources
• Toxicology screening: Urine or blood testing to confirm cannabinoid exposure and exclude other substances

A thorough clinical history — including honest disclosure of cannabis use, frequency, and route of administration (smoked, vaped, ingested) — is essential. Our editorial board strongly encourages patients to be candid with their physicians: non-judgmental assessment is the standard of modern vascular care.

Treatment: From Cessation to Surgery

Cannabis cessation is the single most important therapeutic step. In tobacco-related Buerger’s disease, cessation of tobacco use is well established as capable of stabilizing or improving the condition (Olin JW, N Engl J Med, 2000). Cannabis arteritis outcomes after cessation are less well-characterized, but some published case reports have documented clinical improvement in patients who stopped cannabis use (Disdier P et al., J Rheumatol, 1999; and others in the cannabis arteritis literature).

Medical management mirrors that of other forms of PAD and critical limb ischemia. Both the European Society for Vascular Surgery (ESVS) guidelines and the American Heart Association/American College of Cardiology (AHA/ACC) guidelines on PAD emphasize risk factor modification, antiplatelet therapy, and supervised exercise rehabilitation as cornerstones of management — principles that apply equally to cannabis-associated arterial disease.

For patients requiring vascular interventions, the decision between endovascular (catheter-based, minimally invasive) and open surgical approaches depends on lesion anatomy, patient fitness, and center expertise. Consult your physician or vascular specialist to determine the most appropriate pathway for your individual situation.

Prevention: Protecting Your Vessels

The most effective preventive measure is straightforward, if not always easy: avoid cannabis use, particularly if you have other cardiovascular risk factors such as smoking, hypertension (high blood pressure), diabetes, or a family history of heart or vascular disease.

For those who use cannabis recreationally or medicinally, the following harm-reduction principles are supported by the available evidence:

1. Avoid smoking — combustion products add independent vascular toxicity beyond THC itself; vaporization or oral routes may reduce, but do not eliminate, risk
2. Do not combine cannabis with tobacco — a common practice that compounds vascular harm substantially
3. Disclose use to your healthcare provider — drug interactions and cardiovascular monitoring are only possible with honest disclosure
4. Know your baseline — if you have varicose veins, PAD, or other vascular conditions, discuss cannabis use explicitly with your vascular specialist
5. Monitor for early symptoms — claudication, cold extremities, or palpitations after use are signals that warrant medical evaluation, not dismissal

When to See a Doctor

Seek emergency care immediately if you experience:

• Chest pain, pressure, or tightness after cannabis use
• Sudden neurological symptoms (weakness, speech disturbance, vision loss)
• A limb that becomes acutely cold, pale, and painful (acute limb ischemia — a vascular emergency)

Schedule a non-urgent but prompt appointment with your physician or vascular specialist if:

• You are a cannabis user experiencing leg pain on walking that resolves with rest
• You notice persistent color changes or ulcers on your feet or hands
• You have palpitations or irregular heartbeat associated with cannabis use
• You are a young person with unexplained PAD symptoms

The vascular community is increasingly alert to cannabis-related presentations. Early diagnosis and cessation can prevent progression to limb loss or major cardiac events.

Also available in French

Sources

1. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–2227. PMID: 24897085 [Note: abstract not reviewed; citation provided for reference; independent verification of attributed claims was not possible.]

2. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079–2092. PMID: 28840009 [Note: abstract not reviewed; specific mechanistic claims attributed to this paper should be confirmed against the original publication.]

3. CEIP-A Working Group on Cannabis. Cannabis use: signal of increasing risk of serious cardiovascular disorders. Fundam Clin Pharmacol. 2014;28(3):323–330. PMID: 24102939 [Note: abstract not reviewed; specific findings attributed to this paper should be confirmed against the original publication.]

4. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–2809.

5. United Nations Office on Drugs and Crime (UNODC). World Drug Report. Vienna: UNODC (most recent available year).

6. Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med. 2000;343(12):864–869.

7. Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited — ten new case reports. Angiology. 2001;52(1):1–5. [For cannabis arteritis cessation outcomes, see also the broader cannabis arteritis case-report literature.]

Medical Disclaimer: This article is produced by the Petit Veinard Editorial Board for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. The information presented reflects published scientific literature available at the time of writing and is not a substitute for professional medical consultation. Always consult a qualified physician or vascular specialist before making any decisions regarding your health. If you are experiencing symptoms described in this article, seek medical attention promptly. Petit Veinard is an independent media outlet and has no financial relationships with pharmaceutical or medical device companies.